Progenics Pharmaceuticals (PGNX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.10 -0.43 (-9.49%) 06/19/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.10 unch (unch) -
for Fri, Jun 19th, 2020
Results
download Want to compare other data? Select Fields| Symbol | PGNX | TSHA | PSNL | ||
| Company | Progenics Pharmaceuticals | Taysha Gene Therapies Inc | Personalis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.60 | 1.7800 | 3.75 | ||
| High | 4.79 | 1.8450 | 3.86 | ||
| Low | 3.94 | 1.7550 | 3.70 | ||
| Last | 4.10 | 1.8400 | 3.83 | ||
| Change | -0.43 | +0.0400 | +0.08 | ||
| % Change | -9.39% | +2.22% | +2.13% | ||
| Volume | 34,928,300 | 926,421 | 379,732 | ||
| 20-Day Average Volume | 2,569,575 | 2,129,375 | 642,103 | ||
| Previous Close | 4.53 | 1.8000 | 3.75 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.30 | 1.4128 | 3.39 | ||
| 20-Day Raw Stochastic | 31.13% | 81.18% | 94.86% | ||
| 20-Day Relative Strength | 49.46% | 58.59% | 52.35% | ||
| Weighted Alpha | -27.10 | -29.25 | -45.94 | ||
| Today's Opinion | 8% Sell | 40% Sell | 56% Sell | ||
| Previous Opinion | 16% Buy | 40% Sell | 72% Sell | ||
| Last Month's Opinion | 72% Sell | 24% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.49% since 06/12/20 | +1.40% since 04/22/25 | +12.76% since 04/22/25 | ||
| Low | 3.86 on 06/15/20 | 1.7000 on 04/25/25 | 3.57 on 04/23/25 | ||
| High | 4.79 on 06/19/20 | 1.9800 on 04/23/25 | 3.90 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +12.95% since 05/19/20 | -6.48% since 03/28/25 | +6.22% since 03/28/25 | ||
| Low | 3.72 on 05/20/20 | 1.0500 on 04/09/25 | 2.83 on 04/07/25 | ||
| High | 4.83 on 06/08/20 | 1.9800 on 04/23/25 | 3.90 on 04/28/25 | ||
| 3-Month | |||||
| %Chg | +94.31% since 03/19/20 | +20.33% since 01/29/25 | -23.25% since 01/29/25 | ||
| Low | 2.05 on 03/20/20 | 1.0500 on 04/09/25 | 2.83 on 04/07/25 | ||
| High | 4.83 on 06/08/20 | 1.9800 on 04/23/25 | 6.43 on 02/18/25 | ||
| 6-Month | |||||
| %Chg | -21.76% since 12/19/19 | -3.99% since 10/29/24 | -25.05% since 10/29/24 | ||
| Low | 1.89 on 03/19/20 | 1.0500 on 04/09/25 | 2.83 on 04/07/25 | ||
| High | 6.37 on 12/23/19 | 3.3100 on 12/02/24 | 7.19 on 12/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 355,048 | 369,099 | 331,155 | ||
| Shares Outstanding, K | 86,597 | 205,055 | 88,308 | ||
| Annual Sales | 34,990,000 | 8,330,000 | 84,610,000 | ||
| Annual Net Income | -68,550,000 | -89,300,000 | -81,280,000 | ||
| Last Quarter Sales | 6,250,000 | 2,020,000 | 16,800,000 | ||
| Last Quarter Net Income | -16,800,000 | -18,780,000 | -16,430,000 | ||
| 60-Month Beta | 1.89 | 0.96 | 1.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.07 on 02/26/25 | -0.23 on 02/27/25 | ||
| Latest Earnings Date | 08/14/20 | 05/13/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||